PhytoHealth Corporation (4108) Fair Value & Analysis
Healthcare · TW · Market cap 2.4B TWD
Fair value as of: Jul 11, 2026
From 1 valuation models · updated today
Fair value updated Jul 11, 2026 — revised from 42.43 TWD to 3.95 TWD (−90.7%) since Jun 24, 2026. Share price −3.2% over the past month.
Price vs Fair Value (12 months)
12‑month range 11.55 TWD – 17.30 TWD · fair‑value band 2.60 TWD – 4.93 TWD · the 12.00 TWD price screens above the 3.95 TWD fair value. As of Jul 11, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
PhytoHealth Corporation (4108) currently trades at 12.00 TWD, while our model-based Fair Value estimate is 3.95 TWD — implying the stock looks roughly 67.1% overvalued today. We read business quality at 39/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, PhytoHealth Corporation generated revenue of 139M TWD at a net margin of -42.7%. Revenue grew 13.0% year over year. It earns a return on equity of -4.8%. The balance sheet holds a net cash position of 71.1M TWD. Fundamentals as of Jul 11, 2026
Our scenario range runs from 2.60 TWD (bear case) to 4.93 TWD (bull case); at 12.00 TWD, the current price sits above that range. The share trades about 33% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -23% fair-value upside — at -67%, 4108 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 11, 2026. TTM = trailing twelve months.
About the company
PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. The Medical Diagnosis segment develops and sells smart medical imaging diagnostic products. The Precision Medical Equipment and Instruments segment engages in the research and development, manufacturing, and sale of ultrasound probes and analysis systems. Its products under development include PHN031, which has completed Phase II clinical trials for the treatment of osteoporosis, and PHN033, which has completed Phase II clinical trials for the treatment of diabetic nephropathy. The company is also developing PHN016, which is in Phase II clinical trials for the treatment of cancer, and …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
PhytoHealth Corporation reported revenue of 135M TWD in FY2025 versus 169M TWD in FY2021, a compound −5.5%/yr. Reported net income was −58.2M TWD in FY2025.
Is 4108 fairly valued? → Check now
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 1276 | HK$57.85 | HK$29.84 | -48% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,786 | ₹991.46 | -44% |
| Zoetis Inc Z1TS34 | R$25.93 | R$19.70 | -24% |
| Hansoh Pharmaceutical Group 3692 | HK$29.32 | HK$23.94 | -18% |
| Divi's Laboratories Limited DIVISLAB | ₹6,747 | ₹2,035 | -70% |
| Torrent Pharmaceuticals Limited TORNTPHARM | ₹4,464 | ₹1,504 | -66% |
| Cipla Limited CIPLA | ₹1,416 | ₹1,466 | +4% |
| Zydus Lifesciences Limited ZYDUSLIFE | ₹1,089 | ₹841.98 | -23% |
| Dr. Reddy's Laboratories Limited DRREDDY | ₹1,291 | ₹1,053 | -18% |
| Lupin Limited LUPIN | ₹2,247 | ₹2,697 | +20% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is PhytoHealth Corporation (4108) undervalued?
What is the fair value of 4108?
What is the quality score of 4108?
What is the revenue of PhytoHealth Corporation (4108)?
What is the net profit margin of 4108?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
The 25 strongest value stocks, free every month
Enter your email to get the free monthly Top-25 report of the most undervalued quality stocks from 35,000+ analysed. Unsubscribe anytime.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.